As CML Outcomes Improve, Demand Rises for BCR::ABL1 Testing
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read MorePosted by Chris Wolski | Mar 20, 2023 | Leukemia, Molecular Diagnostic Analyzers |
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read MorePosted by Andy Lundin | Mar 17, 2023 | Disease States |
Multiple sclerosis experts are advocating for genetic testing to identify MS patients at risk of developing side effects from medications.
Read MorePosted by Andy Lundin | Mar 17, 2023 | Company News |
Enzo Biochem, has entered into an agreement for Labcorp to acquire the assets of Enzo’s clinical laboratory division, Enzo Clinical Labs.
Read MorePosted by Andy Lundin | Mar 16, 2023 | Company News, Immunoassay Reagents & test Kits |
U.S. Healthcare professionals can access a new novel NAD+ blood diagnostic test for their patients, following the new partnership.
Read MorePosted by Andy Lundin | Mar 15, 2023 | Disease States |
Scientists developed a test to improve quality of life for infants with HCU—a congenital disease that causes serious complications.
Read More